{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T01:46:08Z","timestamp":1793670368210,"version":"4.5.1"},"reference-count":125,"publisher":"Centers for Disease Control MMWR Office","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["MMWR Recomm. Rep."],"DOI":"10.15585\/mmwr.rr7305a1","type":"journal-article","created":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T14:55:09Z","timestamp":1724770509000},"page":"1-25","source":"Crossref","is-referenced-by-count":240,"title":["Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices \u2014 United States, 2024\u201325 Influenza Season"],"prefix":"10.15585","volume":"73","author":[{"given":"Lisa A.","family":"Grohskopf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill M.","family":"Ferdinands","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenee H.","family":"Blanton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen R.","family":"Broder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Loehr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6224","published-online":{"date-parts":[[2024,8,29]]},"reference":[{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R1","doi-asserted-by":"publisher","first-page":"761","DOI":"10.2105\/AJPH.76.7.761","article-title":"Excess pneumonia and influenza associated hospitalization during influenza epidemics in the United States, 1970-78.","volume":"76","author":"Barker","year":"1986","journal-title":"Am J Public Health"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R2","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1093\/oxfordjournals.aje.a113052","article-title":"Impact of epidemic type A influenza in a defined adult population.","volume":"112","author":"Barker","year":"1980","journal-title":"Am J Epidemiol"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R3","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/irv.12504","article-title":"Risk factors for serious outcomes associated with influenza illness in high- versus low- and middle-income countries: Systematic literature review and meta-analysis.","volume":"12","author":"Coleman","year":"2018","journal-title":"Influenza Other Respir Viruses"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R4","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.vaccine.2006.09.041","article-title":"Influenza- and RSV-associated hospitalizations among adults.","volume":"25","author":"Mullooly","year":"2007","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R5","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1542\/peds.2012-1255","article-title":"The burden of influenza in young children, 2004-2009.","volume":"131","author":"Poehling","year":"2013","journal-title":"Pediatrics"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1056\/NEJMoa054869","article-title":"The underrecognized burden of influenza in young children.","volume":"355","author":"Poehling","year":"2006","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R7","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1001\/jama.2010.479","article-title":"Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States.","volume":"303","author":"Siston","year":"2010","journal-title":"JAMA"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R8","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/irv.12506","article-title":"Effects of seasonal and pandemic influenza on health-related quality of life, work and school absence in England: Results from the Flu Watch cohort study.","volume":"12","author":"Fragaszy","year":"2018","journal-title":"Influenza Other Respir Viruses"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R9","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1097\/JOM.0000000000001120","article-title":"Influenza and workplace productivity loss in working adults.","volume":"59","author":"Van Wormer","year":"2017","journal-title":"J Occup Environ Med"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R10","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/irv.12604","article-title":"The impact of influenza infection on young children, their family and the health care system.","volume":"13","author":"Willis","year":"2019","journal-title":"Influenza Other Respir Viruses"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R11","first-page":"1","article-title":"Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010.","volume":"59","author":"Fiore","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R12","unstructured":"CDC. How flu vaccine effectiveness and efficacy are measured: questions and answers. Atlanta, GA: US Department of Health and Human Services, CDC; 2023. https:\/\/www.cdc.gov\/flu\/vaccines-work\/effectivenessqa.htm"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R13","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/irv.12486","article-title":"Annual estimates of the burden of seasonal influenza in the United States: A tool for strengthening influenza surveillance and preparedness.","volume":"12","author":"Rolfes","year":"2018","journal-title":"Influenza Other Respir Viruses"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R14","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1093\/cid\/ciz075","article-title":"Effects of influenza vaccination in the United States during the 2017\u20132018 influenza season.","volume":"69","author":"Rolfes","year":"2019","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7202a1","article-title":"Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices\u2014United States, 2023\u201324 Influenza Season.","volume":"72","author":"Grohskopf","year":"2022","journal-title":"MMWR Recomm Rep"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R16","unstructured":"Ahmed F. US Advisory Committee on Immunization Practices (ACIP) handbook for developing evidence-based recommendations, version 1.2. Atlanta, GA: US Department of Health and Human Services, CDC; 2013."},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R17","unstructured":"CDC. Advisory Committee on Immunization Practices (ACIP): evidence-based recommendations\u2014GRADE. Atlanta, GA: US Department of Health and Human Services, CDC; 2024. https:\/\/www.cdc.gov\/vaccines\/acip\/recs\/grade\/about-grade.html"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R18","unstructured":"World Health Organization. Recommended composition of influenza virus vaccines for use in the 2024 southern hemisphere influenza season. Genveva, Switzerland: World Health Organization; 2024. https:\/\/www.who.int\/publications\/m\/item\/recommended-composition-of-influenza-virus-vaccines-for-use-in-the-2024-southern-hemisphere-influenza-season"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R19","doi-asserted-by":"publisher","first-page":"2200753","DOI":"10.2807\/1560-7917.ES.2022.27.39.2200753","article-title":"Has influenza B\/Yamagata become extinct and what implications might this have for quadrivalent influenza vaccines?","volume":"27","author":"Paget","year":"2022","journal-title":"Euro Surveill"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R20","unstructured":"CDC. Flu season. Atlanta, GA: US Department of Health and Human Services, CDC; 2023. https:\/\/www.cdc.gov\/flu\/about\/season"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R21","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.vaccine.2014.06.052","article-title":"Waning vaccine protection against influenza A (H3N2) illness in children and older adults during a single season.","volume":"33","author":"Belongia","year":"2015","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R22","doi-asserted-by":"publisher","first-page":"20388","DOI":"10.2807\/ese.18.05.20388-en","article-title":"Decline in influenza vaccine effectiveness with time after vaccination, Navarre, Spain, season 2011\/12.","volume":"18","author":"Castilla","year":"2013","journal-title":"Euro Surveill"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R23","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/cid\/ciw816","article-title":"Intraseason waning of influenza vaccine protection: Evidence from the US Influenza Vaccine Effectiveness Network, 2011-12 through 2014-15.","volume":"64","author":"Ferdinands","year":"2017","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R24","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1093\/cid\/ciab045","article-title":"Waning vaccine effectiveness against influenza-associated hospitalizations among adults, 2015\u20132016 to 2018\u20132019, United States Hospitalized Adult Influenza Vaccine Effectiveness Network.","volume":"73","author":"Ferdinands","year":"2021","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R25","doi-asserted-by":"publisher","first-page":"30201","DOI":"10.2807\/1560-7917.ES.2016.21.16.30201","article-title":"I-MOVE multicentre case-control study 2010\/11 to 2014\/15: Is there within-season waning of influenza type\/subtype vaccine effectiveness with increasing time since vaccination?","volume":"21","author":"Kissling","year":"2016","journal-title":"Euro Surveill"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R26","doi-asserted-by":"publisher","first-page":"20390","DOI":"10.2807\/ese.18.05.20390-en","article-title":"Low and decreasing vaccine effectiveness against influenza A(H3) in 2011\/12 among vaccination target groups in Europe: results from the I-MOVE multicentre case-control study.","volume":"18","author":"Kissling","year":"2013","journal-title":"Euro Surveill"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R27","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.3390\/ijerph18031129","article-title":"Influenza vaccine effectiveness and waning effect in hospitalized older adults. Valencia Region, Spain, 2018\/2019 Season.","volume":"18","author":"Mira-Iglesias","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R28","doi-asserted-by":"publisher","first-page":"3925","DOI":"10.1016\/j.vaccine.2019.03.054","article-title":"Evaluating the effectiveness of the influenza vaccine during respiratory outbreaks in Singapore\u2019s long term care facilities, 2017.","volume":"37","author":"Ng","year":"2019","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R29","doi-asserted-by":"publisher","first-page":"20389","DOI":"10.2807\/ese.18.05.20389-en","article-title":"Vaccine effectiveness of 2011\/12 trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: evidence of waning intra-seasonal protection.","volume":"18","author":"Pebody","year":"2013","journal-title":"Euro Surveill"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R30","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1093\/jpids\/piz077","article-title":"Influenza Vaccine Effectiveness Among Children for the 2017-2018 Season.","volume":"9","author":"Powell","year":"2020","journal-title":"J Pediatric Infect Dis Soc"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R31","doi-asserted-by":"publisher","first-page":"5799","DOI":"10.1016\/j.vaccine.2017.09.035","article-title":"Waning protection of influenza vaccination during four influenza seasons, 2011\/2012 to 2014\/2015.","volume":"35","author":"Puig-Barber\u00e0","year":"2017","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R32","doi-asserted-by":"publisher","first-page":"3907","DOI":"10.1016\/j.vaccine.2016.05.034","article-title":"Influenza vaccine effectiveness: Maintained protection throughout the duration of influenza seasons 2010-2011 through 2013-2014.","volume":"34","author":"Radin","year":"2016","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R33","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1093\/cid\/ciy770","article-title":"Intraseason waning of influenza vaccine effectiveness.","volume":"68","author":"Ray","year":"2019","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R34","doi-asserted-by":"publisher","first-page":"e299","DOI":"10.1017\/S0950268820002952","article-title":"Influenza vaccine failure in the tropics: a retrospective cohort study of waning effectiveness.","volume":"148","author":"Young","year":"2020","journal-title":"Epidemiol Infect"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R35","doi-asserted-by":"publisher","first-page":"888","DOI":"10.3390\/vaccines10060888","article-title":"Waning vaccine protection against influenza among Department of Defense adult beneficiaries in the United States, 2016\u20132017 through 2019\u20132020 influenza seasons.","volume":"10","author":"Hu","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R36","doi-asserted-by":"publisher","first-page":"2634","DOI":"10.1016\/j.vaccine.2019.02.027","article-title":"Intraseason decline in influenza vaccine effectiveness during the 2016 southern hemisphere influenza season: A test-negative design study and phylogenetic assessment.","volume":"37","author":"Regan","year":"2019","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R37","doi-asserted-by":"publisher","first-page":"e1031","DOI":"10.1093\/cid\/ciac577","article-title":"Sustained within-season vaccine effectiveness against influenza-associated hospitalization in children: evidence from the New Vaccine Surveillance Network, 2015\u20132016 through 2019\u20132020.","volume":"76","author":"Sahni","year":"2023","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R38","doi-asserted-by":"publisher","first-page":"3092","DOI":"10.1016\/j.vaccine.2023.03.066","article-title":"Duration of influenza vaccine effectiveness in the elderly in Japan: A retrospective cohort study using large-scale population-based registry data.","volume":"41","author":"Uemura","year":"2023","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R39","doi-asserted-by":"publisher","first-page":"2300239","DOI":"10.2807\/1560-7917.ES.2024.29.8.2300239","article-title":"Measuring waning protection from seasonal influenza vaccination during nine influenza seasons, Ontario, Canada, 2010\/11 to 2018\/19.","volume":"29","author":"Chung","year":"2024","journal-title":"Euro Surveill"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R40","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1080\/14760584.2024.2331073","article-title":"Waning intra-season vaccine effectiveness against influenza A(H3N2) underlines the need for more durable protection.","volume":"23","author":"Domnich","year":"2024","journal-title":"Expert Rev Vaccines"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R41","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1056\/NEJMoa1401480","article-title":"Influenza vaccination of pregnant women and protection of their infants.","volume":"371","author":"Madhi","year":"2014","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R42","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/S1473-3099(17)30252-9","article-title":"Year-round influenza immunisation during pregnancy in Nepal: a phase 4, randomised, placebo-controlled trial.","volume":"17","author":"Steinhoff","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R43","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/S1473-3099(16)30054-8","article-title":"Maternal immunisation with trivalent inactivated influenza vaccine for prevention of influenza in infants in Mali: a prospective, active-controlled, observer-blind, randomised phase 4 trial.","volume":"16","author":"Tapia","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R44","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1056\/NEJMoa0708630","article-title":"Effectiveness of maternal influenza immunization in mothers and infants.","volume":"359","author":"Zaman","year":"2008","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R45","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1093\/infdis\/jix632","article-title":"Duration of influenza vaccine effectiveness: a systematic review, meta-analysis, and meta-regression of test-negative design case-control studies.","volume":"217","author":"Young","year":"2018","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R46","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1093\/cid\/ciz452","article-title":"Waning of influenza vaccine protection: exploring the trade-offs of changes in vaccination timing among older adults.","volume":"70","author":"Ferdinands","year":"2020","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R47","doi-asserted-by":"publisher","first-page":"e135","DOI":"10.1016\/j.amepre.2018.11.015","article-title":"Compressed influenza vaccination in U.S. older adults: a decision analysis.","volume":"56","author":"Smith","year":"2019","journal-title":"Am J Prev Med"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R48","doi-asserted-by":"publisher","first-page":"5910","DOI":"10.1016\/j.vaccine.2018.08.007","article-title":"Within-season influenza vaccine waning suggests potential net benefits to delayed vaccination in older adults in the United States.","volume":"36","author":"Newall","year":"2018","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R49","first-page":"1","article-title":"Immunization of health-care personnel: recommendations of the Advisory Committee on Immunization Practices (ACIP).","volume":"60","author":"CDC","year":"2011","journal-title":"MMWR Recomm Rep"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R50","first-page":"1","article-title":"Influenza vaccination of health-care personnel: recommendations of the Healthcare Infection Control Practices Advisory Committee (HICPAC) and the Advisory Committee on Immunization Practices (ACIP).","volume":"55","author":"Pearson","year":"2006","journal-title":"MMWR Recomm Rep"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R51","unstructured":"Afluria [Package Insert]. Parkville, Victoria, Australia: Seqirus; 2024."},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R52","unstructured":"Fluarix [Package Insert]. Dresden, Germany: GlaxoSmithKline; 2024."},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R53","unstructured":"Flucelvax [Package Insert]. Holly Springs, NC: Seqirus; 2024."},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R54","unstructured":"FluLaval [Package Insert]. Quebec City, QC, Canada: ID Biomedical Corporation of Quebec; 2024."},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R55","unstructured":"Fluzone [Package Insert]. Swiftwater, PA: Sanofi Pasteur; 2024."},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R56","unstructured":"FluMist [Package Insert]. Gaithersburg, MD: MedImmune; 2024."},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R57","unstructured":"Flublok [Package Insert]. Meriden, CT: Protein Sciences; 2024."},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R58","unstructured":"Fluzone High-Dose [Package Insert]. Swiftwater, PA: Sanofi Pasteur; 2024."},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R59","unstructured":"Fluad [Package Insert]. Holly Springs, NC: Seqirus; 2024."},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R60","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.jpeds.2006.06.036","article-title":"Influenza vaccine effectiveness in healthy 6- to 21-month-old children during the 2003-2004 season.","volume":"149","author":"Allison","year":"2006","journal-title":"J Pediatr"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R61","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1542\/peds.2007-3304","article-title":"Vaccine effectiveness against laboratory-confirmed influenza in children 6 to 59 months of age during the 2003-2004 and 2004-2005 influenza seasons.","volume":"122","author":"Eisenberg","year":"2008","journal-title":"Pediatrics"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R62","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1086\/507309","article-title":"Immunogenicity and reactogenicity of 1 versus 2 doses of trivalent inactivated influenza vaccine in vaccine-naive 5-8-year-old children.","volume":"194","author":"Neuzil","year":"2006","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R63","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1542\/peds.2005-0049","article-title":"Effectiveness of the 2003-2004 influenza vaccine among children 6 months to 8 years of age, with 1 vs 2 doses.","volume":"116","author":"Ritzwoller","year":"2005","journal-title":"Pediatrics"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R64","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1001\/archpediatrics.2010.192","article-title":"Maternal influenza vaccination and effect on influenza virus infection in young infants.","volume":"165","author":"Eick","year":"2011","journal-title":"Arch Pediatr Adolesc Med"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R65","doi-asserted-by":"publisher","first-page":"e24","DOI":"10.1097\/AOG.0000000000005479","article-title":"Influenza in pregnancy: prevention and treatment.","volume":"143","author":"American College of Obstetricians and Gynecologists","year":"2024","journal-title":"Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R66","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1093\/cid\/ciu915","article-title":"Maternal influenza immunization and birth outcomes of stillbirth and spontaneous abortion: a systematic review and meta-analysis.","volume":"60","author":"Bratton","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R67","doi-asserted-by":"publisher","first-page":"5026","DOI":"10.1016\/j.vaccine.2013.08.097","article-title":"Risks and safety of pandemic H1N1 influenza vaccine in pregnancy: birth defects, spontaneous abortion, preterm delivery, and small for gestational age infants.","volume":"31","author":"Chambers","year":"2013","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R68","doi-asserted-by":"publisher","first-page":"4443","DOI":"10.1016\/j.vaccine.2016.06.054","article-title":"Safety of the 2010-11, 2011-12, 2012-13, and 2013-14 seasonal influenza vaccines in pregnancy: Birth defects, spontaneous abortion, preterm delivery, and small for gestational age infants, a study from the cohort arm of VAMPSS.","volume":"34","author":"Chambers","year":"2016","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R69","doi-asserted-by":"publisher","first-page":"177.e1","DOI":"10.1016\/j.ajog.2012.07.007","article-title":"Safety of MF59-adjuvanted A\/H1N1 influenza vaccine in pregnancy: a comparative cohort study.","volume":"207","author":"Heikkinen","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R70","doi-asserted-by":"publisher","first-page":"6463","DOI":"10.1016\/j.vaccine.2014.09.054","article-title":"Safety of inactivated monovalent pandemic (H1N1) 2009 vaccination during pregnancy: a population-based study in Taiwan.","volume":"32","author":"Huang","year":"2014","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R71","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1097\/AOG.0b013e318279f56f","article-title":"Trivalent inactivated influenza vaccine and spontaneous abortion.","volume":"121","author":"Irving","year":"2013","journal-title":"Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R72","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1128\/CVI.00375-14","article-title":"Prospective cohort study of the safety of an influenza A(H1N1) vaccine in pregnant Chinese women.","volume":"21","author":"Ma","year":"2014","journal-title":"Clin Vaccine Immunol"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R73","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1016\/j.vaccine.2015.02.068","article-title":"Influenza vaccination during pregnancy: a systematic review of fetal death, spontaneous abortion, and congenital malformation safety outcomes.","volume":"33","author":"McMillan","year":"2015","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R74","doi-asserted-by":"publisher","first-page":"e2794","DOI":"10.1136\/bmj.e2794","article-title":"Vaccination against pandemic A\/H1N1 2009 influenza in pregnancy and risk of fetal death: cohort study in Denmark.","volume":"344","author":"Pasternak","year":"2012","journal-title":"BMJ"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R75","doi-asserted-by":"publisher","first-page":"e51734","DOI":"10.1371\/journal.pone.0051734","article-title":"Evaluating the hazard of foetal death following H1N1 influenza vaccination; a population based cohort study in the UK GPRD.","volume":"7","author":"Sammon","year":"2012","journal-title":"PLoS One"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R76","doi-asserted-by":"publisher","first-page":"4445","DOI":"10.1016\/j.vaccine.2012.04.081","article-title":"A(H1N1)v2009: a controlled observational prospective cohort study on vaccine safety in pregnancy.","volume":"30","author":"Oppermann","year":"2012","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R77","doi-asserted-by":"publisher","first-page":"5314","DOI":"10.1016\/j.vaccine.2017.06.069","article-title":"Association of spontaneous abortion with receipt of inactivated influenza vaccine containing H1N1pdm09 in 2010-11 and 2011-12.","volume":"35","author":"Donahue","year":"2017","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R78","doi-asserted-by":"publisher","first-page":"6673","DOI":"10.1016\/j.vaccine.2019.09.035","article-title":"Inactivated influenza vaccine and spontaneous abortion in the Vaccine Safety Datalink in 2012-13, 2013-14, and 2014-15.","volume":"37","author":"Donahue","year":"2019","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R79","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.vaccine.2020.12.045","article-title":"Reports of cell-based influenza vaccine administered during pregnancy in the Vaccine Adverse Event Reporting System (VAERS), 2013-2020.","volume":"39","author":"Moro","year":"2021","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R80","doi-asserted-by":"crossref","unstructured":"Robinson C, Van Boxmeer J, Tilson H, Outcomes in pregnant persons immunized with a cell-based quadrivalent inactivated influenza vaccine: a prospective observational cohort study. Vaccines (Basel) 2022;10:1600 10.3390\/vaccines10101600.36298465","DOI":"10.3390\/vaccines10101600"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R81","unstructured":"Swamy GK. Clinical Trial to compare safety of recombinant influenza vaccine (RIV4) versus quadrivalent inactivated influenza vaccine (IIV4) in pregnancy. Presented at the Advisory Committee on Immunization Practices meeting, Atlanta, GA; October 20, 2022. https:\/\/stacks.cdc.gov\/view\/cdc\/122379"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R82","unstructured":"CDC. Advisory Committee on Immunization Practices: GRADE: higher dose and adjuvanted influenza vaccines for persons aged \u226565 Years. Atlanta, GA: US Department of Health and Human Services, CDC; 2022. https:\/\/www.cdc.gov\/vaccines\/acip\/recs\/grade\/influenza-older-adults.html"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R83","unstructured":"CDC. Advisory Committee on Immunization Practices: evidence to recommendations (EtR) framework: higher dose and adjuvanted influenza vaccines for persons aged \u226565 years. Atlanta, GA: US Department of Health and Human Services, CDC; 2022. https:\/\/www.cdc.gov\/vaccines\/acip\/recs\/grade\/influenza-older-adults-etr.html"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R84","unstructured":"CDC. Fluview. Weekly influenza surveillance report. Atlanta, GA: US Department of Health and Human Services, CDC; 2024. https:\/\/www.cdc.gov\/flu\/weekly\/index.htm"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R85","doi-asserted-by":"crossref","unstructured":"Thompson WW, Shay DK, Weintraub E, Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003;289:179\u201386 10.1001\/jama.289.2.179.12517228","DOI":"10.1001\/jama.289.2.179"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R86","doi-asserted-by":"crossref","unstructured":"DiazGranados CA. Dunning AJ, Kimmel M, et al. Efficacy of high-dose versus standard-dose influenza vaccine in older adults. N Engl J Med 2014;371:635\u201345. 10.1056\/NEJMoa131572725119609","DOI":"10.1056\/NEJMoa1315727"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R87","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1056\/NEJMoa1608862","article-title":"Efficacy of recombinant influenza vaccine in adults 50 years of age or older.","volume":"376","author":"Dunkle","year":"2017","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R88","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.vaccine.2009.10.037","article-title":"Comparative immunogenicity of recombinant influenza hemagglutinin (rHA) and trivalent inactivated vaccine (TIV) among persons > or =65 years old.","volume":"28","author":"Keitel","year":"2009","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R89","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1093\/infdis\/jiy716","article-title":"Relative effectiveness of cell-cultured and egg-based influenza vaccines among elderly persons in the United States, 2017\u20132018.","volume":"220","author":"Izurieta","year":"2019","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R90","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1093\/infdis\/jiaa080","article-title":"Relative effectiveness of influenza vaccines among the United States elderly, 2018\u20132019.","volume":"222","author":"Izurieta","year":"2020","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R91","doi-asserted-by":"publisher","first-page":"e4251","DOI":"10.1093\/cid\/ciaa1727","article-title":"Comparative effectiveness of influenza vaccines among US Medicare beneficiaries ages 65 years and older during the 2019\u20132020 season.","volume":"73","author":"Izurieta","year":"2021","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R92","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S1473-3099(14)71087-4","article-title":"Comparative effectiveness of high-dose versus standard-dose influenza vaccines in US residents aged 65 years and older from 2012 to 2013 using Medicare data: a retrospective cohort analysis.","volume":"15","author":"Izurieta","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R93","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1093\/infdis\/jiz360","article-title":"Effect of age on relative effectiveness of high-dose versus standard-dose influenza vaccines among US Medicare beneficiaries aged >\/=65 years.","volume":"220","author":"Lu","year":"2019","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R94","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/vaccines8030446","article-title":"Evaluating the relative vaccine effectiveness of adjuvanted trivalent influenza vaccine compared to high-dose trivalent and other egg-based influenza vaccines among older adults in the US during the 2017\u20132018 influenza season.","volume":"8","author":"Pelton","year":"2020","journal-title":"Vaccines (Basel)"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R95","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1093\/cid\/civ261","article-title":"Comparative effectiveness of high-dose versus standard-dose influenza vaccination in community-dwelling veterans.","volume":"61","author":"Richardson","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R96","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1093\/infdis\/jiw641","article-title":"Comparative effectiveness of high-dose versus standard-dose influenza vaccines among US Medicare beneficiaries in preventing postinfluenza deaths during 2012\u20132013 and 2013\u20132014.","volume":"215","author":"Shay","year":"2017","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R97","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1016\/j.vaccine.2019.01.063","article-title":"Analysis of relative effectiveness of high-dose versus standard-dose influenza vaccines using an instrumental variable method.","volume":"37","author":"Young-Xu","year":"2019","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R98","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1093\/infdis\/jiy088","article-title":"Relative vaccine effectiveness of high-dose versus standard-dose influenza vaccines among Veterans Health Administration patients.","volume":"217","author":"Young-Xu","year":"2018","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R99","doi-asserted-by":"crossref","unstructured":"Young-Xu Y, Thornton Snider J, Mahmud SM, High-dose influenza vaccination and mortality among predominantly male, white, senior veterans, United States, 2012\/13 to 2014\/15. Euro Surveill 2020;25:1900401 10.2807\/1560-7917.ES.2020.25.19.1900401.32431290","DOI":"10.2807\/1560-7917.ES.2020.25.19.1900401"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R100","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1016\/j.vaccine.2021.03.054","article-title":"A retrospective cohort study assessing relative effectiveness of adjuvanted versus high-dose trivalent influenza vaccines among older adults in the United States during the 2018-19 influenza season.","volume":"39","author":"Pelton","year":"2021","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R101","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.vaccine.2019.09.105","article-title":"Comparative effectiveness of high dose versus adjuvanted influenza vaccine: A retrospective cohort study.","volume":"38","author":"van Aalst","year":"2020","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R102","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1080\/21645515.2018.1445446","article-title":"Seasonal influenza vaccine in immunocompromised persons.","volume":"14","author":"Bosaeed","year":"2018","journal-title":"Hum Vaccin Immunother"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R103","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1093\/cid\/cit684","article-title":"2013 IDSA clinical practice guideline for vaccination of the immunocompromised host.","volume":"58","author":"Rubin","year":"2014","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R104","unstructured":"CDC. Influenza antiviral medications: summary for clinicians. Atlanta, GA: US Department of Health and Human Services, CDC; 2023. https:\/\/www.cdc.gov\/flu\/professionals\/antivirals\/summary-clinicians.htm"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R105","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/j.jaci.2012.07.046","article-title":"Egg-allergic patients can be safely vaccinated against influenza.","volume":"130","author":"Des Roches","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R106","unstructured":"CDC. Grading of Recommendations, Assessment, Development, and Evaluation (GRADE): safety of influenza vaccines for persons with egg allergy. Atlanta, GA: US Department of Health and Human Services, CDC; 2023. https:\/\/www.cdc.gov\/vaccines\/acip\/recs\/grade\/influenza-egg-allergy.html"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R107","doi-asserted-by":"publisher","first-page":"5618","DOI":"10.1016\/j.vaccine.2017.08.047","article-title":"Postmarketing safety surveillance of trivalent recombinant influenza vaccine: Reports to the Vaccine Adverse Event Reporting System.","volume":"35","author":"Woo","year":"2017","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R108","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1016\/j.vaccine.2021.02.052","article-title":"Postmarketing safety surveillance of quadrivalent recombinant influenza vaccine: Reports to the vaccine adverse event reporting system.","volume":"39","author":"Woo","year":"2021","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R109","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1093\/cid\/ciu948","article-title":"Allergic reactions after egg-free recombinant influenza vaccine: reports to the US Vaccine Adverse Event Reporting System.","volume":"60","author":"Woo","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R110","unstructured":"Kroger A, Bahta L, Long S, Sanchez P. General best practice guidelines for immunization. Atlanta, GA: US Department of Health and Human Services, CDC; 2023. https:\/\/www.cdc.gov\/vaccines\/hcp\/acip-recs\/general-recs\/index.html"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R111","unstructured":"CDC. Flu prevention: information for travelers. Atlanta, GA: US Department of Health and Human Services, CDC; 2024. https:\/\/www.cdc.gov\/flu\/school-business\/travelersfacts.htm"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R112","unstructured":"World Health Organization. Global influenza programme: FluNet. Geneva, Switzerland: World Health Organization; 2024. https:\/\/www.who.int\/tools\/flunet"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R113","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1111\/jtm.12215","article-title":"Influenza outbreaks among passengers and crew on two cruise ships: a recent account of preparedness and response to an ever-present challenge.","volume":"22","author":"Millman","year":"2015","journal-title":"J Travel Med"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R114","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1086\/429243","article-title":"Influenza virus infection in travelers to tropical and subtropical countries.","volume":"40","author":"Mutsch","year":"2005","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R115","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jcv.2013.01.008","article-title":"Incidence and risk factors for acute respiratory illnesses and influenza virus infections in Australian travellers to Asia.","volume":"57","author":"Ratnam","year":"2013","journal-title":"J Clin Virol"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R116","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1086\/374053","article-title":"Large summertime influenza A outbreak among tourists in Alaska and the Yukon Territory.","volume":"36","author":"Uyeki","year":"2003","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R117","unstructured":"Rapivab (peramivir injection) [Package Insert]. Durham, NC: BioCryst; 2024."},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R118","unstructured":"Xofluza (baloxavir marboxil) [Package Insert]. South San Francisco, CA: Genentech; 2022."},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R119","unstructured":"Food and Drug Administration. Guidance for industry: bioavailability and bioequivalence studies for orally administered drug products: general considerations. Silver Spring, MD: US Department of Health and Human Services, Food and Drug Administration; 2003. https:\/\/ipqpubs.com\/wp-content\/uploads\/2020\/12\/BioStudies_OralDosageProducts_March.2003.GUIDANCE.pdf.pdf"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R120","unstructured":"Shingrix [Package Insert]. Durham, NC: GlaxoSmithKline; 2023."},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R121","unstructured":"Arexvy [Package insert]. Durham, NC: GlaxoSmithKline; 2024."},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R122","unstructured":"Heplisav-B [Package Insert]. Emeryville, CA: Dynavax; 2023."},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R123","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.vaccine.2017.08.029","article-title":"Immunogenicity and safety of zoster vaccine live administered with quadrivalent influenza virus vaccine.","volume":"36","author":"Levin","year":"2018","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R124","unstructured":"Schmader K. Safety of Simultaneous Vaccination with Zoster Vaccine Recombinant (RZV) and Quadrivalent Adjuvanted Inactivated Influenza Vaccine (allV4). Presented at the Advisory Committee on Immunization Practices meeting, Atlanta, GA; October 25, 2023. https:\/\/stacks.cdc.gov\/view\/cdc\/134683"},{"key":"key-10.15585\/mmwr.rr7305a1-202408261545-R125","unstructured":"Food and Drug Administration. Vaccines and Related Biological Products Advisory Committee March 5, 2024 Meeting announcement. https:\/\/www.fda.gov\/advisory-committees\/advisory-committee-calendar\/vaccines-and-related-biological-products-advisory-committee-march-5-2024-meeting-announcement"}],"container-title":["MMWR. Recommendations and Reports"],"original-title":[],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T09:32:26Z","timestamp":1732699946000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.cdc.gov\/mmwr\/volumes\/73\/rr\/rr7305a1.htm?s_cid=rr7305a1_w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,29]]},"references-count":125,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,8,29]]}},"URL":"https:\/\/doi.org\/10.15585\/mmwr.rr7305a1","relation":{},"ISSN":["1057-5987","1545-8601"],"issn-type":[{"value":"1057-5987","type":"print"},{"value":"1545-8601","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,8,29]]},"published":{"date-parts":[[2024,8,29]]}}}